CYCLOSPORINE

CYCLOSPORINE was reported 112834 times

CYCLOSPORINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYMPHOID TISSUE HYPOPLASIA 97 0.6340
1 THYMUS HYPOPLASIA 96 0.5517
2 CYTOMEGALOVIRUS ANTIGEN POSITIVE 84 0.4590
3 RED BLOOD CELL SEDIMENTATION RATE 107 0.3835
4 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1040 0.3759
5 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 92 0.3755
6 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 269 0.3741
7 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 526 0.3723
8 GRAFT DYSFUNCTION 99 0.3474
9 CHRONIC GRAFT VERSUS HOST DISEASE 1214 0.3359
10 TRANSPLANT DYSFUNCTION 591 0.3309
11 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 113 0.3104
12 CYSTITIS VIRAL 117 0.3055
13 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 638 0.2995
14 VIRAL HAEMORRHAGIC CYSTITIS 211 0.2963
15 ENCEPHALITIS CYTOMEGALOVIRUS 128 0.2922
16 GRANULOMA SKIN 235 0.2862
17 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 265 0.2862
18 ACUTE GRAFT VERSUS HOST DISEASE 1306 0.2850
19 GRAFT VERSUS HOST DISEASE IN LIVER 204 0.2849
20 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 367 0.2787
21 GRAFT VERSUS HOST DISEASE IN SKIN 591 0.2680
22 PRODUCT DROPPER ISSUE 202 0.2567
23 CYTOMEGALOVIRUS INFECTION REACTIVATION 1116 0.2524
24 SMOOTH MUSCLE CELL NEOPLASM 105 0.2512
25 BK VIRUS INFECTION 848 0.2512
26 SCLERAL HYPERAEMIA 168 0.2467
27 GRAFT VERSUS HOST DISEASE 1744 0.2423
28 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 387 0.2188
29 KAPOSI'S SARCOMA 109 0.2171
30 CHRONIC ALLOGRAFT NEPHROPATHY 167 0.2133
31 LYMPHOCELE 140 0.2108
32 EPSTEIN-BARR VIRAEMIA 229 0.2065
33 DISSEMINATED ASPERGILLOSIS 97 0.2055
34 BLOOD PARATHYROID HORMONE DECREASED 281 0.1895
35 ADENOVIRUS INFECTION 535 0.1843
36 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 894 0.1755
37 HEART TRANSPLANT REJECTION 182 0.1753
38 ASPERGILLOSIS 229 0.1752
39 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 81 0.1727
40 FOREIGN BODY SENSATION IN EYES 1088 0.1705
41 KIDNEY TRANSPLANT REJECTION 818 0.1703
42 CHRONIC SPONTANEOUS URTICARIA 196 0.1690
43 EPSTEIN-BARR VIRUS INFECTION 1047 0.1674
44 TRANSPLANT REJECTION 1311 0.1635
45 ENGRAFTMENT SYNDROME 95 0.1607
46 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 125 0.1598
47 GINGIVAL HYPERTROPHY 237 0.1561
48 CYTOMEGALOVIRUS VIRAEMIA 690 0.1550
49 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 181 0.1508
50 OBLITERATIVE BRONCHIOLITIS 197 0.1500
51 COMPLICATIONS OF TRANSPLANTED KIDNEY 338 0.1489
52 CYSTITIS HAEMORRHAGIC 598 0.1482
53 POLYOMAVIRUS VIRAEMIA 155 0.1460
54 PNEUMONIA CYTOMEGALOVIRAL 283 0.1456
55 SUPERFICIAL INJURY OF EYE 158 0.1446
56 LUNG TRANSPLANT REJECTION 95 0.1439
57 EYE IRRITATION 8140 0.1413
58 LIVER TRANSPLANT REJECTION 253 0.1407
59 CYTOMEGALOVIRUS INFECTION 2328 0.1399
60 PARVOVIRUS B19 INFECTION 123 0.1374
61 INSTILLATION SITE PAIN 336 0.1355
62 MULTIPLE USE OF SINGLE-USE PRODUCT 741 0.1319
63 HUMAN HERPESVIRUS 6 INFECTION 248 0.1311
64 PANNICULITIS 309 0.1276
65 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 420 0.1270
66 CEREBRAL TOXOPLASMOSIS 118 0.1263
67 VIRAEMIA 174 0.1255
68 TRANSPLANT FAILURE 305 0.1243
69 APLASTIC ANAEMIA 620 0.1186
70 RENAL TUBULAR ATROPHY 101 0.1145
71 GRAFT LOSS 82 0.1131
72 MYCOBACTERIUM CHELONAE INFECTION 83 0.1123
73 PRODUCT CONTAINER ISSUE 962 0.1121
74 THROMBOTIC MICROANGIOPATHY 1070 0.1097
75 ACUTE MYELOID LEUKAEMIA RECURRENT 232 0.1080
76 ENTHESOPATHY 165 0.1054
77 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 247 0.1053
78 VENOOCCLUSIVE DISEASE 262 0.1045
79 ENCEPHALITIS VIRAL 123 0.1010
80 ERYTHRODERMIC PSORIASIS 83 0.1007
81 RHEUMATOID NODULE 276 0.1001
82 EYELID PAIN 201 0.0988
83 SOFT TISSUE DISORDER 109 0.0983
84 BLOOD IRON ABNORMAL 96 0.0983
85 STEROID DEPENDENCE 86 0.0979
86 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 157 0.0979
87 CYTOMEGALOVIRUS TEST POSITIVE 169 0.0947
88 NEPHROPATHY TOXIC 1060 0.0943
89 VENOOCCLUSIVE LIVER DISEASE 446 0.0902
90 CYTOMEGALOVIRUS COLITIS 207 0.0899
91 PSEUDOMONAL SEPSIS 155 0.0884
92 KIDNEY FIBROSIS 153 0.0881
93 SYSTEMIC MYCOSIS 100 0.0856
94 JC VIRUS INFECTION 136 0.0850
95 ORAL ADMINISTRATION COMPLICATION 79 0.0849
96 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 630 0.0839
97 CYTOMEGALOVIRUS CHORIORETINITIS 160 0.0820
98 TOXOPLASMOSIS 87 0.0806
99 LYMPHOPROLIFERATIVE DISORDER 236 0.0803
100 LEUKAEMIA RECURRENT 134 0.0792
101 HISTIOCYTOSIS HAEMATOPHAGIC 232 0.0781
102 BRONCHOPULMONARY ASPERGILLOSIS 602 0.0776
103 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 728 0.0762
104 STENOTROPHOMONAS INFECTION 103 0.0759
105 ALANINE AMINOTRANSFERASE ABNORMAL 160 0.0758
106 RENAL TUBULAR INJURY 92 0.0757
107 EYE DISCHARGE 768 0.0738
108 INFECTION REACTIVATION 82 0.0716
109 HIRSUTISM 95 0.0714
110 EYE PAIN 4023 0.0712
111 DRUG TOLERANCE DECREASED 200 0.0711
112 VARICELLA ZOSTER VIRUS INFECTION 147 0.0708
113 ENTEROBACTER INFECTION 119 0.0707
114 PNEUMOCYSTIS JIROVECI PNEUMONIA 156 0.0700
115 SECONDARY IMMUNODEFICIENCY 84 0.0691
116 ENTEROCOCCAL INFECTION 332 0.0686
117 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 174 0.0654
118 APLASIA PURE RED CELL 225 0.0653
119 SKIN NECROSIS 338 0.0651
120 MUCORMYCOSIS 168 0.0646
121 CORNEAL ABRASION 87 0.0634
122 STEM CELL TRANSPLANT 158 0.0632
123 ASPERGILLUS INFECTION 413 0.0629
124 TENOSYNOVITIS 172 0.0623
125 ABNORMAL SENSATION IN EYE 264 0.0614
126 EYELID IRRITATION 154 0.0613
127 NOCARDIOSIS 157 0.0613
128 PSEUDOMONAS INFECTION 512 0.0596
129 HAEMOLYTIC URAEMIC SYNDROME 138 0.0595
130 HYPOGAMMAGLOBULINAEMIA 389 0.0592
131 CONCOMITANT DISEASE PROGRESSION 115 0.0588
132 BACTERIAL SEPSIS 191 0.0586
133 KLEBSIELLA INFECTION 294 0.0581
134 CUSHINGOID 186 0.0579
135 C-REACTIVE PROTEIN ABNORMAL 371 0.0578
136 OCULAR DISCOMFORT 643 0.0572
137 ERYTHEMA OF EYELID 294 0.0542
138 HYPERTRICHOSIS 100 0.0539
139 NEPHROTIC SYNDROME 368 0.0536
140 PNEUMOMEDIASTINUM 97 0.0536
141 PNEUMATOSIS INTESTINALIS 153 0.0536
142 SYSTEMIC CANDIDA 134 0.0533
143 NEPHRECTOMY 79 0.0532
144 LACRIMATION INCREASED 1590 0.0526
145 OCULAR HYPERAEMIA 2480 0.0522
146 STAPHYLOCOCCAL BACTERAEMIA 227 0.0522
147 NEOPLASM SKIN 81 0.0521
148 PNEUMONIA KLEBSIELLA 95 0.0516
149 PNEUMONIA VIRAL 161 0.0505
150 PYODERMA GANGRENOSUM 181 0.0503
151 CRYPTOCOCCOSIS 81 0.0497
152 STAPHYLOCOCCAL SEPSIS 243 0.0492
153 PNEUMONIA FUNGAL 194 0.0491
154 APLASIA 94 0.0480
155 HERPES SIMPLEX 311 0.0478
156 OVARIAN CYST 476 0.0476
157 MYCOBACTERIAL INFECTION 82 0.0476
158 BRAIN ABSCESS 116 0.0458
159 LEUKOENCEPHALOPATHY 169 0.0453
160 DRY EYE 2243 0.0449
161 LUPUS NEPHRITIS 84 0.0449
162 BONE MARROW TRANSPLANT 85 0.0448
163 RED BLOOD CELL SEDIMENTATION RATE INCREASED 487 0.0440
164 OPPORTUNISTIC INFECTION 81 0.0438
165 PNEUMOCYSTIS JIROVECII PNEUMONIA 430 0.0428
166 PUSTULAR PSORIASIS 146 0.0425
167 SERUM FERRITIN INCREASED 224 0.0424
168 THROMBOTIC THROMBOCYTOPENIC PURPURA 149 0.0422
169 ESCHERICHIA SEPSIS 122 0.0421
170 CAPILLARY LEAK SYNDROME 87 0.0420
171 GLOMERULONEPHRITIS 102 0.0416
172 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 104 0.0403
173 EYE PRURITUS 1315 0.0391
174 ASTHENOPIA 214 0.0389
175 ACTINIC KERATOSIS 101 0.0389
176 BASAL CELL CARCINOMA 606 0.0388
177 GROWTH RETARDATION 114 0.0387
178 GRANULOMA 134 0.0387
179 EYELID MARGIN CRUSTING 111 0.0384
180 EYELID DISORDER 88 0.0381
181 MUCOSAL INFLAMMATION 988 0.0377
182 DEMYELINATION 154 0.0375
183 BACTERAEMIA 446 0.0375
184 SCLERODERMA 136 0.0374
185 SYNOVITIS 673 0.0373
186 PHOTOPHOBIA 675 0.0359
187 AUTOIMMUNE HAEMOLYTIC ANAEMIA 121 0.0353
188 HAEMODIALYSIS 295 0.0351
189 HEPATOSPLENOMEGALY 90 0.0350
190 MULTI-ORGAN FAILURE 604 0.0349
191 DRUG ERUPTION 614 0.0346
192 BACTERIAL INFECTION 646 0.0346
193 SERUM SICKNESS 96 0.0344
194 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 79 0.0343
195 HAEMOLYSIS 262 0.0339
196 CANDIDIASIS 135 0.0336
197 SWELLING OF EYELID 211 0.0336
198 BLOOD PRESSURE SYSTOLIC ABNORMAL 83 0.0335
199 ESCHERICHIA INFECTION 276 0.0335
200 HYPERCALCAEMIA 414 0.0335
201 MULTIPLE ORGAN DYSFUNCTION SYNDROME 944 0.0333
202 SKIN PLAQUE 281 0.0333
203 PRODUCT DELIVERY MECHANISM ISSUE 178 0.0331
204 EYELIDS PRURITUS 102 0.0327
205 LYMPHADENITIS 79 0.0326
206 SQUAMOUS CELL CARCINOMA 306 0.0325
207 RENAL TRANSPLANT 117 0.0324
208 CLOSTRIDIUM DIFFICILE COLITIS 338 0.0318
209 RHINOVIRUS INFECTION 123 0.0316
210 SQUAMOUS CELL CARCINOMA OF SKIN 190 0.0314
211 BLOOD CREATININE INCREASED 2052 0.0314
212 RENAL TUBULAR NECROSIS 306 0.0312
213 RENAL TUBULAR DISORDER 87 0.0309
214 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 253 0.0306
215 IMMUNE THROMBOCYTOPENIA 140 0.0305
216 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 197 0.0303
217 KERATITIS 92 0.0302
218 RHEUMATOID FACTOR POSITIVE 174 0.0301
219 BLEPHARITIS 120 0.0299
220 BLOOD LACTATE DEHYDROGENASE INCREASED 469 0.0296
221 DIFFUSE LARGE B-CELL LYMPHOMA 227 0.0294
222 LUNG INFILTRATION 257 0.0291
223 B-CELL LYMPHOMA 98 0.0288
224 PNEUMONIA BACTERIAL 264 0.0287
225 HEPATIC FIBROSIS 98 0.0285
226 DERMATITIS EXFOLIATIVE GENERALISED 99 0.0284
227 EYE INFLAMMATION 271 0.0284
228 C-REACTIVE PROTEIN INCREASED 1027 0.0282
229 PULMONARY ALVEOLAR HAEMORRHAGE 157 0.0280
230 DRUG TOLERANCE 141 0.0278
231 RENAL FAILURE CHRONIC 213 0.0277
232 PROTEINURIA 523 0.0275
233 THERAPY PARTIAL RESPONDER 426 0.0273
234 MYOPATHY 234 0.0271
235 HYPERURICAEMIA 110 0.0267
236 CONTRAINDICATED PRODUCT ADMINISTERED 806 0.0266
237 ESCHERICHIA URINARY TRACT INFECTION 113 0.0266
238 OLIGURIA 165 0.0266
239 EYELID OEDEMA 308 0.0265
240 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 101 0.0264
241 PYELONEPHRITIS 229 0.0264
242 HEPATITIS B 157 0.0260
243 RENAL IMPAIRMENT 2185 0.0260
244 SEPTIC SHOCK 1118 0.0257
245 ACUTE RESPIRATORY DISTRESS SYNDROME 444 0.0251
246 HYPOALBUMINAEMIA 195 0.0251
247 DRUG LEVEL INCREASED 414 0.0250
248 ULCER 396 0.0249
249 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1360 0.0248
250 EYE INFECTION 279 0.0247
251 ENCEPHALITIS 170 0.0245
252 PULMONARY TUBERCULOSIS 104 0.0243
253 INTRACRANIAL PRESSURE INCREASED 135 0.0242
254 LYMPHOPENIA 342 0.0242
255 BLOOD BILIRUBIN INCREASED 651 0.0241
256 THERAPY NON-RESPONDER 1078 0.0240
257 GUILLAIN-BARRE SYNDROME 116 0.0240
258 PANCYTOPENIA 1334 0.0238
259 IMMUNOSUPPRESSION 210 0.0238
260 BONE EROSION 84 0.0237
261 LIVER TRANSPLANT 86 0.0236
262 OESOPHAGEAL CANDIDIASIS 94 0.0236
263 HYPERBILIRUBINAEMIA 244 0.0235
264 HERPES VIRUS INFECTION 135 0.0234
265 TONGUE ULCERATION 79 0.0234
266 HAEMORRHAGIC DIATHESIS 83 0.0233
267 BONE MARROW FAILURE 472 0.0232
268 TREATMENT FAILURE 1924 0.0232
269 TONGUE DISORDER 168 0.0232
270 DISSEMINATED INTRAVASCULAR COAGULATION 324 0.0230
271 BLOOD UREA INCREASED 385 0.0230
272 DRUG RESISTANCE 590 0.0229
273 NEUROTOXICITY 399 0.0227
274 SKIN PAPILLOMA 91 0.0227
275 ENDOCARDITIS 116 0.0226
276 HEPATIC FUNCTION ABNORMAL 842 0.0225
277 ANURIA 193 0.0224
278 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 160 0.0223
279 HAEMOLYTIC ANAEMIA 199 0.0222
280 EYE SWELLING 819 0.0220
281 PULMONARY HAEMORRHAGE 172 0.0220
282 BRONCHIECTASIS 145 0.0215
283 VISION BLURRED 2947 0.0214
284 CONCOMITANT DISEASE AGGRAVATED 132 0.0214
285 STREPTOCOCCAL INFECTION 119 0.0214
286 AZOTAEMIA 84 0.0210
287 SKIN ULCER 542 0.0209
288 GENERALISED OEDEMA 259 0.0209
289 CYTOPENIA 254 0.0207
290 URINE OUTPUT DECREASED 181 0.0207
291 SPLENOMEGALY 240 0.0205
292 LOW BIRTH WEIGHT BABY 162 0.0204
293 STAPHYLOCOCCAL INFECTION 672 0.0204
294 BLOOD CREATINE INCREASED 90 0.0203
295 NECROSIS 113 0.0203
296 PSORIATIC ARTHROPATHY 822 0.0202
297 FUNGAL INFECTION 674 0.0202
298 ORGANISING PNEUMONIA 100 0.0202
299 CANDIDA INFECTION 340 0.0201
300 BREATH SOUNDS ABNORMAL 99 0.0201
301 SKIN LESION 550 0.0200
302 SEPSIS 2197 0.0197
303 DYSLIPIDAEMIA 100 0.0197
304 LEUKOPENIA 977 0.0195
305 DRUG INTOLERANCE 1867 0.0193
306 PAPILLOEDEMA 87 0.0192
307 HYDRONEPHROSIS 144 0.0192
308 LIVER FUNCTION TEST ABNORMAL 558 0.0192
309 TOXIC ENCEPHALOPATHY 97 0.0191
310 BLOOD PRESSURE DIASTOLIC INCREASED 88 0.0190
311 SKIN MASS 127 0.0190
312 RENAL FAILURE ACUTE 807 0.0190
313 ACUTE MYELOID LEUKAEMIA 293 0.0188
314 BLOOD URIC ACID INCREASED 108 0.0187
315 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 192 0.0187
316 CACHEXIA 96 0.0186
317 CHOLANGITIS 114 0.0184
318 DISEASE RECURRENCE 869 0.0182
319 HORDEOLUM 79 0.0182
320 BRAIN OEDEMA 229 0.0181
321 INCORRECT PRODUCT STORAGE 237 0.0180
322 HYPERCHOLESTEROLAEMIA 174 0.0180
323 SKIN INFECTION 202 0.0180
324 PATHOGEN RESISTANCE 164 0.0180
325 PRODUCT USE IN UNAPPROVED INDICATION 4398 0.0177
326 MYASTHENIA GRAVIS 143 0.0177
327 MYELODYSPLASTIC SYNDROME 256 0.0177
328 FEBRILE NEUTROPENIA 1174 0.0177
329 PRODUCT USE COMPLAINT 278 0.0176
330 HEPATIC ENZYME ABNORMAL 88 0.0176
331 ALANINE AMINOTRANSFERASE INCREASED 1080 0.0176
332 RENAL CELL CARCINOMA 85 0.0174
333 ASPARTATE AMINOTRANSFERASE INCREASED 921 0.0173
334 RESPIRATORY FAILURE 1262 0.0173
335 DRUG LEVEL DECREASED 176 0.0173
336 TENDERNESS 180 0.0173
337 CHOLESTASIS 331 0.0172
338 MALABSORPTION 90 0.0172
339 HEPATITIS C 207 0.0171
340 THERAPEUTIC PRODUCT EFFECT DECREASED 767 0.0171
341 COVID-19 PNEUMONIA 201 0.0170
342 REBOUND EFFECT 192 0.0170
343 PRE-EXISTING CONDITION IMPROVED 106 0.0170
344 TRANSAMINASES INCREASED 377 0.0169
345 INFLAMMATION 872 0.0169
346 PIGMENTATION DISORDER 104 0.0168
347 HEPATOTOXICITY 374 0.0168
348 NEPHROPATHY 156 0.0167
349 HERPES ZOSTER 956 0.0166
350 FOETAL GROWTH RESTRICTION 101 0.0166
351 UROSEPSIS 152 0.0165
352 RHABDOMYOLYSIS 685 0.0164
353 ACUTE PULMONARY OEDEMA 92 0.0164
354 NEUROLOGICAL SYMPTOM 93 0.0163
355 PROTEIN URINE PRESENT 81 0.0162
356 ORAL DISORDER 119 0.0162
357 GAMMA-GLUTAMYLTRANSFERASE INCREASED 355 0.0160
358 EYE DISORDER 523 0.0159
359 CATARACT 947 0.0159
360 CATARACT OPERATION 94 0.0158
361 VITREOUS FLOATERS 155 0.0158
362 THERAPEUTIC RESPONSE DECREASED 956 0.0158
363 ENTEROCOLITIS 90 0.0156
364 PERIORBITAL SWELLING 87 0.0154
365 HYPERTRANSAMINASAEMIA 107 0.0154
366 GLAUCOMA 295 0.0153
367 DEVICE RELATED INFECTION 235 0.0153
368 BLOOD ALKALINE PHOSPHATASE INCREASED 379 0.0152
369 BLOOD ALBUMIN DECREASED 121 0.0152
370 HEPATOMEGALY 149 0.0151
371 FEAR OF INJECTION 108 0.0151
372 AGRANULOCYTOSIS 281 0.0151
373 HEPATITIS CHOLESTATIC 91 0.0151
374 AUTOIMMUNE HEPATITIS 105 0.0151
375 HAEMODYNAMIC INSTABILITY 114 0.0149
376 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1062 0.0149
377 PULMONARY FIBROSIS 286 0.0149
378 PERICARDIAL EFFUSION 342 0.0148
379 GRAND MAL CONVULSION 136 0.0147
380 HYDROCEPHALUS 80 0.0147
381 PAPULE 103 0.0146
382 INFECTION 2112 0.0146
383 HEPATITIS 373 0.0146
384 TOXIC EPIDERMAL NECROLYSIS 221 0.0145
385 LIQUID PRODUCT PHYSICAL ISSUE 106 0.0145
386 HEPATIC FAILURE 437 0.0145
387 RALES 84 0.0145
388 STOMATITIS 877 0.0144
389 RENAL FAILURE 1914 0.0144
390 TENDONITIS 223 0.0144
391 PLATELET COUNT ABNORMAL 87 0.0144
392 BLOOD PRESSURE SYSTOLIC INCREASED 280 0.0143
393 TUBULOINTERSTITIAL NEPHRITIS 269 0.0143
394 VIRAL INFECTION 477 0.0143
395 GLUCOSE TOLERANCE IMPAIRED 84 0.0142
396 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 86 0.0141
397 SHOCK HAEMORRHAGIC 115 0.0141
398 ENCEPHALOPATHY 346 0.0141
399 INTERSTITIAL LUNG DISEASE 682 0.0141
400 EYELID PTOSIS 143 0.0141
401 LYMPHADENOPATHY 498 0.0141
402 JOINT EFFUSION 97 0.0141
403 GASTROINTESTINAL INFECTION 126 0.0140
404 PLATELET COUNT INCREASED 182 0.0139
405 ANGIOPATHY 78 0.0139
406 RESPIRATORY DISTRESS 384 0.0139
407 ACUTE RESPIRATORY FAILURE 267 0.0139
408 THROMBOCYTOPENIA 1539 0.0137
409 SKIN ATROPHY 79 0.0137
410 INTRAOCULAR PRESSURE INCREASED 174 0.0136
411 PSORIASIS 1776 0.0136
412 UVEITIS 184 0.0136
413 VASCULITIS 158 0.0135
414 RESPIRATORY SYNCYTIAL VIRUS INFECTION 118 0.0135
415 MOUTH ULCERATION 285 0.0135
416 MALIGNANT MELANOMA 181 0.0135
417 HYPERTRIGLYCERIDAEMIA 79 0.0135
418 HYPERLIPIDAEMIA 160 0.0134
419 VISUAL ACUITY REDUCED 443 0.0133
420 HELICOBACTER INFECTION 137 0.0133
421 DUODENAL ULCER PERFORATION 99 0.0133
422 EYE MOVEMENT DISORDER 91 0.0133
423 MULTIPLE ALLERGIES 103 0.0131
424 OSTEOPENIA 198 0.0130
425 MYOSITIS 117 0.0130
426 FOOT DEFORMITY 144 0.0130
427 HAEMORRHAGE INTRACRANIAL 194 0.0130
428 ASCITES 381 0.0129
429 RHEUMATOID ARTHRITIS 1470 0.0129
430 EXPIRED PRODUCT ADMINISTERED 427 0.0128
431 ORAL CANDIDIASIS 169 0.0128
432 END STAGE RENAL DISEASE 233 0.0128
433 ANGIOEDEMA 564 0.0127
434 LYMPHOMA 197 0.0127
435 HAND DEFORMITY 167 0.0127
436 RENAL DISORDER 588 0.0126
437 GASTROENTERITIS 183 0.0125
438 HAEMATURIA 426 0.0124
439 HAIR GROWTH ABNORMAL 86 0.0124
440 PRODUCT PACKAGING ISSUE 118 0.0124
441 DIALYSIS 175 0.0123
442 IMPAIRED GASTRIC EMPTYING 168 0.0123
443 CARDIAC FAILURE ACUTE 82 0.0123
444 PETECHIAE 128 0.0123
445 HEPATIC CIRRHOSIS 230 0.0122
446 PYREXIA 4229 0.0122
447 RASH PUSTULAR 89 0.0122
448 SKIN HYPERPIGMENTATION 105 0.0122
449 AUTOIMMUNE DISORDER 119 0.0122
450 HEPATIC ENZYME INCREASED 831 0.0122
451 ARTHROPATHY 674 0.0121
452 PLATELET COUNT DECREASED 1292 0.0121
453 ACUTE KIDNEY INJURY 1844 0.0120
454 IMMUNE SYSTEM DISORDER 158 0.0120
455 LUNG INFECTION 186 0.0120
456 RETINAL DETACHMENT 110 0.0120
457 LARGE INTESTINE PERFORATION 83 0.0119
458 ARTHRITIS 940 0.0119
459 CELLULITIS 602 0.0119
460 CONJUNCTIVITIS 221 0.0119
461 ABSCESS 189 0.0118
462 DRUG TOXICITY 161 0.0118
463 DRUG INTERACTION 1874 0.0118
464 MADAROSIS 137 0.0118
465 HAEMATOCRIT DECREASED 234 0.0118
466 RETINAL HAEMORRHAGE 84 0.0118
467 ORAL HERPES 230 0.0118
468 PLEURAL EFFUSION 716 0.0118
469 OEDEMA 638 0.0118
470 DERMATITIS 246 0.0117
471 ANOREXIA 151 0.0117
472 HYPERTENSION 2471 0.0117
473 BLOOD PRESSURE DIASTOLIC DECREASED 86 0.0116
474 GLOMERULAR FILTRATION RATE DECREASED 143 0.0116
475 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 557 0.0116
476 LUNG DISORDER 564 0.0115
477 OFF LABEL USE 10019 0.0114
478 LEUKOCYTOSIS 207 0.0114
479 CLOSTRIDIUM DIFFICILE INFECTION 249 0.0114
480 OSTEOMYELITIS 206 0.0114
481 SCRATCH 120 0.0114
482 MALNUTRITION 127 0.0113
483 APHTHOUS ULCER 88 0.0113
484 DIARRHOEA HAEMORRHAGIC 106 0.0113
485 ATELECTASIS 109 0.0113
486 INFUSION RELATED REACTION 745 0.0112
487 OSTEOPOROSIS 460 0.0112
488 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 790 0.0111
489 SKIN DISORDER 370 0.0111
490 PRODUCT ADMINISTRATION INTERRUPTED 87 0.0111
491 ORAL PAIN 247 0.0110
492 RESPIRATORY TRACT INFECTION 285 0.0109
493 CONDITION AGGRAVATED 3324 0.0109
494 PRODUCT DOSE OMISSION 713 0.0109
495 LIVER DISORDER 483 0.0109
496 ACIDOSIS 83 0.0108
497 JAUNDICE 292 0.0108
498 PURPURA 96 0.0108
499 PNEUMOTHORAX 172 0.0108
500 HAEMATOTOXICITY 103 0.0108
501 HYPOXIA 380 0.0108
502 PHOTOSENSITIVITY REACTION 178 0.0108
503 HAEMOGLOBIN DECREASED 1104 0.0107
504 HYPERKALAEMIA 376 0.0107
505 RENAL CYST 85 0.0107
506 FIBROMYALGIA 260 0.0107
507 WOUND INFECTION 117 0.0107
508 PNEUMONIA 3455 0.0107
509 ARTHROPOD BITE 79 0.0106
510 PRODUCT STORAGE ERROR 932 0.0106
511 HYPERTENSIVE CRISIS 118 0.0106
512 QUALITY OF LIFE DECREASED 141 0.0105
513 COAGULOPATHY 175 0.0105
514 BLOOD MAGNESIUM DECREASED 90 0.0104
515 PULMONARY CONGESTION 137 0.0104
516 BLOOD CREATINE PHOSPHOKINASE INCREASED 299 0.0104
517 RASH PRURITIC 562 0.0104
518 HEPATIC STEATOSIS 193 0.0104
519 POOR QUALITY PRODUCT ADMINISTERED 109 0.0103
520 ANKYLOSING SPONDYLITIS 136 0.0103
521 IMMUNODEFICIENCY 153 0.0103
522 FACIAL PAIN 91 0.0102
523 HEPATIC ENCEPHALOPATHY 95 0.0102
524 PERICARDITIS 171 0.0102
525 DIABETES MELLITUS 775 0.0102
526 DISEASE PROGRESSION 1197 0.0101
527 OSTEOARTHRITIS 428 0.0101
528 MYOCLONUS 120 0.0101
529 NEUTROPENIA 1368 0.0101
530 CYSTITIS 320 0.0100
531 DRUG INEFFECTIVE 13231 0.0100
532 NO THERAPEUTIC RESPONSE 122 0.0100
533 SKIN CANCER 213 0.0099
534 MACULAR DEGENERATION 118 0.0099
535 PRODUCT ADMINISTRATION ERROR 199 0.0098
536 UPPER-AIRWAY COUGH SYNDROME 81 0.0098
537 SUBARACHNOID HAEMORRHAGE 100 0.0098
538 PERITONITIS 203 0.0098
539 THERAPY CESSATION 503 0.0098
540 ANAEMIA 1866 0.0098
541 URTICARIA 1636 0.0098
542 CARDIOMEGALY 120 0.0097
543 CHOLECYSTITIS 116 0.0097
544 JOINT RANGE OF MOTION DECREASED 130 0.0097
545 ANAPHYLACTIC REACTION 535 0.0097
546 SECRETION DISCHARGE 121 0.0097
547 RASH MACULO-PAPULAR 211 0.0095
548 SHOCK 218 0.0095
549 ELECTROLYTE IMBALANCE 110 0.0095
550 VITAMIN D DEFICIENCY 92 0.0094
551 POST PROCEDURAL COMPLICATION 181 0.0094
552 OSTEONECROSIS 309 0.0094
553 DIPLOPIA 244 0.0094
554 JOINT SWELLING 1131 0.0094
555 EYE HAEMORRHAGE 125 0.0094
556 PHARYNGITIS 116 0.0093
557 ILEUS 116 0.0093
558 PEMPHIGUS 116 0.0093
559 EAR DISCOMFORT 95 0.0092
560 OESOPHAGITIS 101 0.0092
561 UPPER RESPIRATORY TRACT INFECTION 427 0.0092
562 SCIATICA 146 0.0091
563 SYSTEMIC LUPUS ERYTHEMATOSUS 325 0.0091
564 VISUAL IMPAIRMENT 1132 0.0091
565 PRODUCT USE ISSUE 1715 0.0091
566 CEREBRAL INFARCTION 222 0.0091
567 IMPAIRED HEALING 297 0.0090
568 PREMATURE DELIVERY 144 0.0090
569 DRUG-INDUCED LIVER INJURY 283 0.0090
570 ALTERED STATE OF CONSCIOUSNESS 195 0.0090
571 GOUT 161 0.0090
572 NODULE 117 0.0090
573 STATUS EPILEPTICUS 101 0.0089
574 POLYNEUROPATHY 107 0.0089
575 HYPERSENSITIVITY 1649 0.0089
576 GINGIVAL BLEEDING 121 0.0089
577 HEMIPARESIS 150 0.0088
578 MUSCULOSKELETAL DISORDER 168 0.0088
579 ADRENAL INSUFFICIENCY 107 0.0088
580 JOINT INJURY 188 0.0088
581 PULMONARY MASS 131 0.0088
582 CEREBRAL HAEMORRHAGE 314 0.0088
583 DECREASED IMMUNE RESPONSIVENESS 86 0.0088
584 LIVER FUNCTION TEST INCREASED 188 0.0087
585 BURNING SENSATION 613 0.0087
586 PULMONARY HYPERTENSION 182 0.0087
587 MASS 122 0.0087
588 MUSCULOSKELETAL STIFFNESS 764 0.0087
589 PREMATURE BABY 262 0.0087
590 SKIN HAEMORRHAGE 129 0.0087
591 WOUND 243 0.0087
592 EAR PAIN 169 0.0087
593 BLOOD POTASSIUM INCREASED 141 0.0087
594 BLOOD CHOLESTEROL INCREASED 403 0.0086
595 PANCREATITIS ACUTE 194 0.0086
596 MYELOSUPPRESSION 310 0.0086
597 CAESAREAN SECTION 100 0.0086
598 MITRAL VALVE INCOMPETENCE 97 0.0086
599 SINUSITIS 873 0.0085
600 PAIN OF SKIN 229 0.0085
601 HEPATIC CYTOLYSIS 108 0.0085
602 ERYTHEMA 1735 0.0084
603 PNEUMONITIS 228 0.0084
604 URINARY TRACT INFECTION 1425 0.0083
605 SCAB 95 0.0083
606 RESPIRATORY DISORDER 249 0.0083
607 METABOLIC ACIDOSIS 266 0.0083
608 WHITE BLOOD CELL COUNT INCREASED 319 0.0083
609 DYSURIA 305 0.0083
610 CONVULSION 473 0.0083
611 BLOOD TRIGLYCERIDES INCREASED 146 0.0083
612 BODY TEMPERATURE INCREASED 168 0.0082
613 RED BLOOD CELL COUNT DECREASED 235 0.0082
614 GASTRIC ULCER 156 0.0082
615 MYOCARDITIS 94 0.0082
616 RHINORRHOEA 526 0.0081
617 EPISTAXIS 608 0.0081
618 ACNE 614 0.0081
619 JOINT DISLOCATION 85 0.0080
620 LYMPHOCYTE COUNT DECREASED 142 0.0080
621 TACHYPNOEA 109 0.0080
622 COLITIS 303 0.0080
623 LIVER INJURY 195 0.0079
624 PRODUCT PRESCRIBING ISSUE 173 0.0079
625 ATAXIA 94 0.0079
626 BRONCHITIS 586 0.0079
627 ACUTE HEPATIC FAILURE 108 0.0079
628 GASTROINTESTINAL DISORDER 708 0.0079
629 NECK PAIN 439 0.0078
630 HEPATOCELLULAR INJURY 111 0.0078
631 DERMATITIS CONTACT 89 0.0078
632 CENTRAL NERVOUS SYSTEM LESION 107 0.0078
633 SEASONAL ALLERGY 110 0.0078
634 MELAENA 171 0.0078
635 GASTRITIS 203 0.0077
636 PRESCRIBED UNDERDOSE 153 0.0077
637 TRANSFUSION 80 0.0076
638 BLOOD PRESSURE INCREASED 1167 0.0076
639 OBESITY 121 0.0076
640 ACCIDENTAL EXPOSURE TO PRODUCT 782 0.0076
641 CARPAL TUNNEL SYNDROME 106 0.0076
642 FLUID OVERLOAD 110 0.0076
643 CHRONIC KIDNEY DISEASE 573 0.0075
644 SNEEZING 169 0.0075
645 METASTASES TO LUNG 87 0.0075
646 PERIPHERAL SWELLING 1160 0.0075
647 UPPER LIMB FRACTURE 150 0.0075
648 DEPRESSED LEVEL OF CONSCIOUSNESS 297 0.0075
649 ROTATOR CUFF SYNDROME 96 0.0075
650 DIVERTICULITIS 207 0.0075
651 BLOOD PRESSURE FLUCTUATION 178 0.0074
652 BLINDNESS 301 0.0074
653 INFLUENZA 821 0.0074
654 PRODUCT PRESCRIBING ERROR 175 0.0073
655 SINUS CONGESTION 99 0.0073
656 ALOPECIA 1438 0.0073
657 SINUS DISORDER 145 0.0073
658 SCAR 125 0.0073
659 CIRCULATORY COLLAPSE 124 0.0073
660 HYPOTHYROIDISM 232 0.0073
661 INTENTIONAL PRODUCT USE ISSUE 636 0.0073
662 WHITE BLOOD CELL COUNT DECREASED 777 0.0072
663 INTESTINAL PERFORATION 80 0.0071
664 DEAFNESS 186 0.0071
665 PRURITUS 2733 0.0071
666 PULMONARY OEDEMA 318 0.0071
667 LOCALISED INFECTION 171 0.0071
668 CARDIAC FAILURE 567 0.0071
669 SKIN FISSURES 138 0.0071
670 PRODUCTIVE COUGH 337 0.0071
671 FEEDING DISORDER 143 0.0070
672 GASTROINTESTINAL HAEMORRHAGE 588 0.0070
673 SLEEP APNOEA SYNDROME 134 0.0070
674 MOBILITY DECREASED 504 0.0070
675 COVID-19 1227 0.0070
676 GENERAL PHYSICAL HEALTH DETERIORATION 808 0.0070
677 OEDEMA PERIPHERAL 849 0.0070
678 FACE OEDEMA 117 0.0069
679 NERVOUS SYSTEM DISORDER 216 0.0069
680 MUSCULOSKELETAL PAIN 359 0.0068
681 HYPERGLYCAEMIA 248 0.0068
682 MUSCULAR WEAKNESS 761 0.0067
683 GLOSSODYNIA 149 0.0066
684 BLISTER 373 0.0066
685 SWELLING FACE 432 0.0066
686 OROPHARYNGEAL PAIN 613 0.0066
687 GASTROENTERITIS VIRAL 119 0.0066
688 DYSPNOEA EXERTIONAL 248 0.0066
689 NEUTROPHIL COUNT DECREASED 268 0.0066
690 ABDOMINAL PAIN 1529 0.0066
691 HYPOMAGNESAEMIA 91 0.0065
692 DRUG EXPOSURE DURING PREGNANCY 222 0.0065
693 BURSITIS 79 0.0065
694 PNEUMONIA ASPIRATION 162 0.0065
695 CARDIOGENIC SHOCK 92 0.0064
696 HAEMORRHOIDS 125 0.0064
697 HAEMATOMA 166 0.0064
698 ECZEMA 335 0.0064
699 TENDON RUPTURE 79 0.0064
700 MUSCULOSKELETAL DISCOMFORT 110 0.0064
701 HAEMOPTYSIS 178 0.0064
702 BLOOD SODIUM DECREASED 120 0.0064
703 SWELLING 595 0.0064
704 EAR INFECTION 169 0.0063
705 APHASIA 191 0.0063
706 RASH 2754 0.0063
707 STEVENS-JOHNSON SYNDROME 140 0.0063
708 PAIN IN EXTREMITY 1848 0.0063
709 CHILLS 735 0.0063
710 SENSORY DISTURBANCE 100 0.0062
711 DISCOMFORT 380 0.0062
712 CARDIOMYOPATHY 92 0.0062
713 SKIN EXFOLIATION 525 0.0062
714 CHOLELITHIASIS 204 0.0062
715 DYSPHAGIA 588 0.0062
716 TOOTH INFECTION 81 0.0061
717 INCORRECT DOSE ADMINISTERED 1397 0.0061
718 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1102 0.0061
719 EJECTION FRACTION DECREASED 95 0.0061
720 GAIT INABILITY 203 0.0061
721 ANKLE FRACTURE 94 0.0061
722 HEADACHE 3802 0.0061
723 NASAL CONGESTION 355 0.0060
724 COLON CANCER 90 0.0060
725 SKIN REACTION 85 0.0060
726 MENTAL STATUS CHANGES 167 0.0060
727 SKIN DISCOLOURATION 275 0.0060
728 RASH PAPULAR 134 0.0060
729 DRY MOUTH 484 0.0060
730 ARTHRALGIA 2474 0.0059
731 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 153 0.0059
732 OXYGEN SATURATION DECREASED 334 0.0059
733 NEURALGIA 144 0.0059
734 LIMB DISCOMFORT 183 0.0059
735 MIGRAINE 564 0.0059
736 COUGH 1655 0.0059
737 HERNIA 114 0.0059
738 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 101 0.0059
739 GALLBLADDER DISORDER 105 0.0059
740 HIP ARTHROPLASTY 90 0.0059
741 DIARRHOEA 3784 0.0059
742 NASOPHARYNGITIS 1079 0.0058
743 MYALGIA 991 0.0058
744 THROAT IRRITATION 261 0.0058
745 SURGERY 341 0.0058
746 BLINDNESS UNILATERAL 82 0.0058
747 CONTUSION 558 0.0058
748 LIP SWELLING 192 0.0058
749 EOSINOPHILIA 101 0.0058
750 ORAL DISCOMFORT 80 0.0058
751 ATRIAL FIBRILLATION 549 0.0056
752 KIDNEY INFECTION 110 0.0056
753 TOOTH DISORDER 124 0.0056
754 GENERALISED TONIC-CLONIC SEIZURE 92 0.0056
755 DERMATITIS ATOPIC 293 0.0056
756 COLITIS ULCERATIVE 248 0.0055
757 RIB FRACTURE 114 0.0055
758 PRODUCT AVAILABILITY ISSUE 126 0.0055
759 GASTRIC DISORDER 189 0.0055
760 HYPONATRAEMIA 309 0.0055
761 SLEEP DISORDER 387 0.0055
762 RASH ERYTHEMATOUS 261 0.0055
763 LOWER RESPIRATORY TRACT INFECTION 248 0.0054
764 JOINT STIFFNESS 143 0.0054
765 PANCREATITIS 288 0.0054
766 CHROMATURIA 123 0.0054
767 PAIN IN JAW 154 0.0054
768 WEIGHT DECREASED 1517 0.0054
769 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 159 0.0054
770 EMOTIONAL DISORDER 167 0.0054
771 NEUROPATHY PERIPHERAL 515 0.0054
772 BLOOD PRESSURE DECREASED 358 0.0054
773 LIMB INJURY 146 0.0054
774 IRRITABLE BOWEL SYNDROME 115 0.0054
775 PAIN 3290 0.0054
776 DYSARTHRIA 201 0.0053
777 BLOOD PRESSURE ABNORMAL 106 0.0053
778 MENTAL DISORDER 232 0.0053
779 MATERNAL EXPOSURE DURING PREGNANCY 474 0.0053
780 HEART RATE INCREASED 526 0.0053
781 HYPOCALCAEMIA 100 0.0053
782 ABDOMINAL DISCOMFORT 885 0.0053
783 INTERVERTEBRAL DISC PROTRUSION 115 0.0053
784 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1064 0.0052
785 SPINAL FRACTURE 105 0.0052
786 TOOTHACHE 94 0.0052
787 EPILEPSY 158 0.0052
788 RESPIRATORY TRACT CONGESTION 82 0.0052
789 NIGHT SWEATS 166 0.0051
790 PRODUCT DISPENSING ERROR 112 0.0051
791 FRACTURE 97 0.0051
792 TACHYCARDIA 455 0.0051
793 TREMOR 850 0.0051
794 FOOT FRACTURE 97 0.0051
795 HYPOKALAEMIA 235 0.0051
796 VOMITING 2388 0.0051
797 DYSPHONIA 296 0.0051
798 TYPE 2 DIABETES MELLITUS 170 0.0050
799 NEOPLASM MALIGNANT 335 0.0050
800 MUSCLE SPASMS 921 0.0050
801 DISORIENTATION 198 0.0050
802 TINNITUS 229 0.0050
803 DEEP VEIN THROMBOSIS 322 0.0050
804 THERAPEUTIC RESPONSE UNEXPECTED 222 0.0049
805 TASTE DISORDER 100 0.0049
806 RASH MACULAR 172 0.0049
807 INSOMNIA 1309 0.0049
808 LABORATORY TEST ABNORMAL 145 0.0049
809 ACUTE MYOCARDIAL INFARCTION 144 0.0049
810 DEHYDRATION 647 0.0048
811 BACK PAIN 1124 0.0048
812 NAUSEA 3828 0.0048
813 FLUID RETENTION 246 0.0048
814 ILLNESS 498 0.0048
815 CORONARY ARTERY DISEASE 146 0.0048
816 HAEMATOCHEZIA 266 0.0048
817 DYSGEUSIA 358 0.0048
818 COMA 228 0.0048
819 HALLUCINATION, VISUAL 101 0.0048
820 FULL BLOOD COUNT DECREASED 96 0.0048
821 ASTHENIA 1790 0.0048
822 EATING DISORDER 101 0.0047
823 DYSPNOEA 2684 0.0047
824 GAIT DISTURBANCE 907 0.0047
825 WEIGHT INCREASED 1057 0.0047
826 ANGINA PECTORIS 135 0.0047
827 RENAL INJURY 139 0.0047
828 KNEE ARTHROPLASTY 98 0.0047
829 HEART RATE DECREASED 163 0.0046
830 GASTROOESOPHAGEAL REFLUX DISEASE 373 0.0046
831 TOXICITY TO VARIOUS AGENTS 781 0.0046
832 SWOLLEN TONGUE 144 0.0046
833 FATIGUE 3585 0.0046
834 MALAISE 2008 0.0046
835 DISABILITY 90 0.0045
836 HAEMORRHAGE 475 0.0045
837 PRODUCT COMPLAINT 115 0.0045
838 CARDIOVASCULAR DISORDER 115 0.0045
839 URINARY INCONTINENCE 134 0.0045
840 CONFUSIONAL STATE 729 0.0045
841 HYPOAESTHESIA 673 0.0045
842 ILL-DEFINED DISORDER 272 0.0045
843 INTESTINAL OBSTRUCTION 168 0.0045
844 BONE DISORDER 81 0.0044
845 BONE PAIN 260 0.0044
846 ABDOMINAL DISTENSION 462 0.0044
847 HYPOPHAGIA 113 0.0044
848 PULMONARY EMBOLISM 419 0.0044
849 ADVERSE DRUG REACTION 396 0.0044
850 FALL 1464 0.0044
851 CARDIAC ARREST 361 0.0044
852 SPEECH DISORDER 229 0.0044
853 HYPOTENSION 876 0.0044
854 ADVERSE EVENT 401 0.0043
855 DRUG DOSE OMISSION 719 0.0043
856 WRONG TECHNIQUE IN DRUG USAGE PROCESS 158 0.0043
857 HAEMATEMESIS 110 0.0043
858 ARRHYTHMIA 205 0.0043
859 COGNITIVE DISORDER 200 0.0043
860 DECREASED APPETITE 986 0.0042
861 FAECES DISCOLOURED 92 0.0042
862 CYTOKINE RELEASE SYNDROME 85 0.0042
863 CHEST PAIN 775 0.0042
864 DELIRIUM 144 0.0041
865 NEPHROLITHIASIS 190 0.0041
866 MOVEMENT DISORDER 133 0.0041
867 INTENTIONAL DOSE OMISSION 118 0.0041
868 THROMBOSIS 332 0.0041
869 MUSCLE TWITCHING 95 0.0041
870 DYSPEPSIA 405 0.0041
871 BALANCE DISORDER 354 0.0041
872 PARAESTHESIA 641 0.0041
873 HALLUCINATION 307 0.0041
874 PRODUCT DOSE OMISSION ISSUE 1196 0.0041
875 VERTIGO 247 0.0040
876 THERAPY INTERRUPTED 288 0.0040
877 HIP FRACTURE 129 0.0040
878 SEIZURE 462 0.0040
879 LOSS OF CONSCIOUSNESS 511 0.0040
880 FEELING HOT 243 0.0040
881 WHEEZING 234 0.0039
882 POLLAKIURIA 164 0.0039
883 ANAPHYLACTIC SHOCK 101 0.0039
884 HOT FLUSH 295 0.0039
885 DRY SKIN 518 0.0039
886 DYSSTASIA 113 0.0039
887 FEELING ABNORMAL 927 0.0039
888 FOETAL EXPOSURE DURING PREGNANCY 313 0.0038
889 ABDOMINAL PAIN UPPER 792 0.0038
890 INJURY 270 0.0038
891 PRURITUS GENERALISED 83 0.0038
892 THERAPEUTIC RESPONSE SHORTENED 127 0.0038
893 CHEST DISCOMFORT 392 0.0038
894 AMNESIA 249 0.0038
895 BLOOD POTASSIUM DECREASED 115 0.0038
896 ASTHMA 431 0.0038
897 AGEUSIA 95 0.0038
898 ACCIDENTAL OVERDOSE 138 0.0038
899 LETHARGY 217 0.0038
900 PSYCHOTIC DISORDER 111 0.0038
901 CONSTIPATION 815 0.0037
902 HYPOACUSIS 160 0.0037
903 RASH GENERALISED 96 0.0037
904 URINARY RETENTION 123 0.0037
905 TRANSIENT ISCHAEMIC ATTACK 123 0.0036
906 DIZZINESS 1818 0.0036
907 PALLOR 99 0.0036
908 INTENTIONAL PRODUCT MISUSE 318 0.0036
909 HEART RATE IRREGULAR 82 0.0036
910 HEAD INJURY 114 0.0036
911 CARDIAC FAILURE CONGESTIVE 287 0.0036
912 ABASIA 88 0.0036
913 NERVOUSNESS 184 0.0035
914 FEELING COLD 98 0.0035
915 ABDOMINAL PAIN LOWER 89 0.0035
916 TREATMENT NONCOMPLIANCE 192 0.0035
917 DEMENTIA 98 0.0035
918 DRUG EFFECT INCOMPLETE 127 0.0035
919 FLATULENCE 197 0.0035
920 RECTAL HAEMORRHAGE 149 0.0035
921 CRYING 126 0.0035
922 DISTURBANCE IN ATTENTION 186 0.0034
923 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 80 0.0034
924 THROAT TIGHTNESS 92 0.0034
925 BRADYCARDIA 180 0.0034
926 DEPRESSION 772 0.0034
927 LUNG NEOPLASM MALIGNANT 139 0.0034
928 ROAD TRAFFIC ACCIDENT 140 0.0033
929 EXPOSURE DURING PREGNANCY 206 0.0033
930 ANXIETY 932 0.0033
931 UNEVALUABLE EVENT 247 0.0033
932 PLASMA CELL MYELOMA 127 0.0033
933 DEPRESSED MOOD 172 0.0033
934 MEMORY IMPAIRMENT 447 0.0033
935 SKIN IRRITATION 148 0.0032
936 CARDIO-RESPIRATORY ARREST 135 0.0032
937 PALPITATIONS 372 0.0032
938 INTERNATIONAL NORMALISED RATIO INCREASED 90 0.0032
939 SOMNOLENCE 634 0.0031
940 GLYCOSYLATED HAEMOGLOBIN INCREASED 79 0.0031
941 FEMUR FRACTURE 96 0.0031
942 FREQUENT BOWEL MOVEMENTS 83 0.0031
943 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 159 0.0030
944 INFLUENZA LIKE ILLNESS 250 0.0030
945 ABORTION SPONTANEOUS 121 0.0030
946 CARDIAC DISORDER 280 0.0030
947 SYNCOPE 296 0.0030
948 HYPERHIDROSIS 379 0.0029
949 DEATH 2521 0.0029
950 DRUG ADMINISTRATION ERROR 89 0.0029
951 HYPERSOMNIA 83 0.0029
952 MYOCARDIAL INFARCTION 501 0.0029
953 PANIC ATTACK 103 0.0028
954 SKIN BURNING SENSATION 202 0.0028
955 HYPOGLYCAEMIA 136 0.0028
956 DRUG EFFECT DECREASED 150 0.0028
957 CEREBROVASCULAR ACCIDENT 461 0.0027
958 INJECTION SITE REACTION 187 0.0027
959 MEDICATION ERROR 151 0.0027
960 PRODUCT QUALITY ISSUE 363 0.0027
961 AGITATION 194 0.0026
962 INJECTION SITE BRUISING 209 0.0026
963 DYSKINESIA 103 0.0025
964 NEOPLASM PROGRESSION 88 0.0025
965 RESTLESSNESS 91 0.0025
966 PRODUCT SUBSTITUTION ISSUE 141 0.0024
967 MALIGNANT NEOPLASM PROGRESSION 246 0.0024
968 IRRITABILITY 142 0.0024
969 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 79 0.0023
970 FLUSHING 237 0.0023
971 HOSPITALISATION 355 0.0023
972 EMOTIONAL DISTRESS 274 0.0023
973 BLOOD GLUCOSE INCREASED 413 0.0022
974 SUICIDAL IDEATION 199 0.0022
975 INJECTION SITE SWELLING 166 0.0022
976 OVERDOSE 454 0.0021
977 ABNORMAL BEHAVIOUR 83 0.0021
978 INJECTION SITE PRURITUS 135 0.0020
979 INJECTION SITE HAEMORRHAGE 159 0.0020
980 INJECTION SITE ERYTHEMA 233 0.0019
981 UNDERDOSE 135 0.0018
982 INJECTION SITE PAIN 564 0.0018
983 BREAST CANCER 168 0.0018
984 MULTIPLE SCLEROSIS 86 0.0018
985 NO ADVERSE EVENT 320 0.0018
986 BLOOD GLUCOSE DECREASED 84 0.0017
987 DEVICE ISSUE 150 0.0017
988 DEVICE MALFUNCTION 107 0.0015
989 DRUG DEPENDENCE 117 0.0007